Take heed to this text |
The Corin Group PLC has recently announced that it has secured 401(k) clearance from the U.S., following a rigorous examination process. The United States Food and Drug Administration has approved the Unity Knee medial constrained, or MC, tibial insert. The corporation has stated that this feature enables surgeons to independently stabilise the medial compartment throughout both standard and robotically assisted whole knee replacement surgery, commonly referred to as TKA.
The Unity Knee MC Tibial Insert was engineered to facilitate a natural restoration of knee movement patterns by providing medial condyle stabilization while allowing for controlled lateral gliding. Corin indicated that their component is suitable for use with or without the posterior cruciate ligament (PCL).
Since its 2012 introduction, the Cirencester, UK-based Unity Knee has been employed in over 75,000 surgical procedures. Throughout the UK, Corin asserted that the system showcased an unprecedented level of efficiency. And, in fact, many Australian implant registries are focused on refining the model?
.
The Unity Knee MC, a modular prosthetic solution designed for everyday life, seamlessly integrates with the innovative ApolloKnee robotic system.
Manufactured with expertise from ECiMa bearing technology, the Unity Knee MC Insert boasts a unique vitamin E-enriched, highly cross-linked polyethylene composition that yields exceptional wear resistance, remarkable oxidative stability, and superior mechanical performance. As part of the Unity Knee system, ApolloKnee combines cutting-edge technology with Corin’s expertise to deliver the next generation of robotic-assisted orthopedic solutions.
“Studies have shown that a well-balanced joint has a more significant impact on overall knee replacement outcomes than merely achieving proper joint alignment.” – Christopher Plaskos, Ph.D. As Vice Chairman for Worldwide Medical Innovation at Corin.
As engineers successfully integrate Unity Knee MC’s precision with ApolloKnee’s advanced soft-tissue balancing, a paradigm shift in joint kinematics and stability is anticipated throughout the entire range of motion, revolutionizing the field. “We envision that this innovation will provide patients with a more lifelike and natural-feeling knee.”
ApolloKnee’s innovative technology provides a pre-operative, dual-compartment assessment of joint stability, allowing surgeons to fine-tune knee function in real-time prior to bone resections, thereby optimizing patient outcomes. “The combination of advanced implant design and innovative robotic-assisted technologies aims to optimize patient outcomes and satisfaction.”
Corin intends to expand its portfolio of products.
“Corin’s latest FDA clearance for the Unity Knee MC and PS-C Tibial Inserts expands the scope of possibilities for surgeons to deliver personalized dynamic knee stability solutions.” “These advancements enable us to respond promptly to market demands while consistently delivering exceptional enhancements.”
“We are expecting further regulatory approvals in the coming months, which will enhance the capabilities of our implant, Apollo, as well as our CorinConnect digital portfolio.” “With our agile R&D pipeline, we stay dedicated to offering differentiated options that improve affected person outcomes.”
The Unity Knee MC Tibial Insert is exclusively available within the United States. via a controlled market introduction.
The company has established a fusion of robotics, artificial intelligence, and data to design, execute, and analyze, coupled with clinically verified implants, aimed at delivering enhanced outcomes and maximizing value for patients, surgeons, and providers.
This content is syndicated from a sibling website.